Bridgeway Capital Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Bridgeway Capital Management’s Portfolio BIOR Stock Details BIOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,650	Closed	-$29.2K	–	1379
2024 Q1	$29.2K	Sell	2,650 -1,078	-29%	-$11.7K	﹤0.01%	1286
2023 Q4	$50.3K	Hold	3,728	–	–	﹤0.01%	1312
2023 Q3	$80.9K	Buy	3,728 +2,000	+116%	+$64.1K	﹤0.01%	1256
2023 Q2	$66.5K	Hold	1,728	–	–	﹤0.01%	1312
2023 Q1	$47.9K	Hold	1,728	–	–	﹤0.01%	1314
2022 Q4	$56.9K	Hold	1,728	–	–	﹤0.01%	1286
2022 Q3	$209K	Hold	1,728	–	–	0.01%	1132
2022 Q2	$302K	Buy	+1,728	New	+$364K	0.01%	995

Other funds holding BIOR

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Bridgeway Capital Management's BIOR Position: Q2 2024 in Review

Bridgeway Capital Management sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q2 2024, closing a stake of 2,650 shares — an estimated $29.2K sold.

Bridgeway Capital Management first reported a position in BIOR in Q2 2022 and held it in 8 quarters. The position peaked at $302K in Q2 2022. 26 funds tracked by Wall St. Rank hold BIOR as of Q2 2024.

Bridgeway Capital Management reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Bridgeway Capital Management sold 2,650 Biora Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $29.2K.
Bridgeway Capital Management first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
Bridgeway Capital Management's Biora Therapeutics, Inc. Common Stock position peaked at $302K in Q2 2022.
26 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Bridgeway Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.